Hideki Nakashima

Pharmacophore identification of a chemokine receptor (CXCR4) antagonist, T22 ([Tyr(5,12),Lys7]-polyphemusin II), which specifically blocks T cell-line-tropic HIV-1 infection.

A. Otaka, H. Tamamura, R. Arakaki, 1998, Bioorganic & medicinal chemistry.

Effective lowly cytotoxic analogs of an HIV-cell fusion inhibitor, T22 ([Tyr5,12, Lys7]-polyphemusin II).

A. Otaka, H. Tamamura, R. Arakaki, 1998, Bioorganic & medicinal chemistry.

Actinohivin, a novel anti-HIV protein from an actinomycete that inhibits syncytium formation: isolation, characterization, and biological activities.

S. Ōmura, M. Oheda, Y. Takahashi, 2001, Biochemical and biophysical research communications.

A single treatment with microcapsules containing a CXCR4 antagonist suppresses pulmonary metastasis of murine melanoma.

H. Tamamura, N. Fujii, H. Nakashima, 2004, Biochemical and biophysical research communications.